Hang Yang Selected Research

C 684

10/2021	Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene.
1/2020	Generation of a human induced pluripotent stem cell line (NCCDFWi001-A) from a Marfan syndrome patient carrying two FBN1 variants (c.2613A > C and c.684_736 + 4del).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hang Yang Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 07/2011
18	Inflammation (Inflammations) 04/2022 - 01/2014
16	Infections 07/2022 - 09/2016
8	COVID-19 07/2022 - 01/2021
7	Neoplasm Metastasis (Metastasis) 10/2021 - 02/2015
6	Lymphoma (Lymphomas) 01/2022 - 09/2015
5	Cholestasis 11/2020 - 08/2016
4	Reperfusion Injury 08/2022 - 12/2020
4	Ischemic Stroke 04/2022 - 01/2017
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2018
4	Fibrosis (Cirrhosis) 01/2021 - 01/2016
3	Wounds and Injuries (Trauma) 05/2022 - 06/2011
3	Stroke (Strokes) 04/2022 - 01/2017
3	Myocardial Infarction 04/2022 - 01/2020
3	Thoracic Aortic Aneurysm 02/2022 - 12/2021
3	Non-alcoholic Fatty Liver Disease 01/2022 - 08/2013
3	Nasopharyngeal Carcinoma 01/2022 - 01/2017
3	Carcinogenesis 01/2021 - 01/2015
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2016
3	Bacterial Infections (Bacterial Infection) 12/2020 - 08/2017
3	Squamous Cell Carcinoma of Head and Neck 11/2018 - 01/2015
3	Carcinoma (Carcinomatosis) 06/2017 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 03/2022 - 01/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2016
2	Aortic Aneurysm (Aneurysm, Aortic) 01/2022 - 01/2022
2	Marfan Syndrome (Marfan's Syndrome) 10/2021 - 01/2020
2	Pathologic Constriction (Stenosis) 07/2021 - 10/2017
2	Hypoxia (Hypoxemia) 05/2021 - 01/2020
2	Sepsis (Septicemia) 04/2021 - 08/2019
2	Ischemia 01/2021 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2020
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 11/2020 - 01/2016
2	Hyponatremia 06/2018 - 01/2016
2	Hemorrhage 02/2018 - 06/2017
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 12/2015
2	Breast Neoplasms (Breast Cancer) 12/2017 - 07/2015
2	Virus Diseases (Viral Diseases) 01/2017 - 09/2016
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2017 - 12/2015

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 06/2022 - 08/2013
12	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2015
6	Biological ProductsIBA 01/2022 - 09/2016
5	Therapeutic UsesIBA 07/2022 - 01/2017
5	Pharmaceutical PreparationsIBA 01/2022 - 06/2011
5	Anti-Bacterial Agents (Antibiotics)IBA 04/2021 - 10/2012
5	Bile Acids and Salts (Bile Acids)IBA 08/2020 - 01/2016
4	MicroRNAs (MicroRNA)IBA 10/2021 - 02/2013
4	CytokinesIBA 12/2017 - 01/2015
3	EnzymesIBA 07/2022 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022 - 01/2020
3	Phosphotransferases (Kinase)IBA 06/2022 - 05/2020
3	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2014
3	RNA (Ribonucleic Acid)IBA 02/2022 - 07/2015
3	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 02/2022 - 12/2021
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2022
3	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2019
3	Sirtuin 1IBA 12/2017 - 12/2016
3	Messenger RNA (mRNA)IBA 07/2015 - 01/2015
2	Alkaline PhosphataseIBA 07/2022 - 01/2017
2	CatalaseIBA 07/2022 - 01/2016
2	Caspase 8 (Caspase-8)IBA 07/2022 - 06/2022
2	Caspase 3 (Caspase-3)IBA 07/2022 - 06/2022
2	LipopolysaccharidesIBA 06/2022 - 01/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2022 - 02/2013
2	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 11/2015
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 04/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 10/2020
2	UbiquitinIBA 01/2022 - 01/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2021
2	pegaspargase (Oncaspar)FDA Link 01/2022 - 01/2022
2	SaltsIBA 01/2022 - 06/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2021
2	GlucocorticoidsIBA 10/2021 - 01/2021
2	C 684IBA 10/2021 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2020
2	VaccinesIBA 01/2021 - 06/2017
2	Janus KinasesIBA 01/2021 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2017
2	C-Reactive ProteinIBA 01/2021 - 01/2017
2	Janus Kinase InhibitorsIBA 01/2021 - 01/2021
2	Long Noncoding RNAIBA 11/2020 - 01/2017
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 08/2020 - 11/2016
2	N 30IBA 01/2020 - 02/2015
2	Rituximab (Mabthera)FDA Link 01/2019 - 01/2018
2	SodiumIBA 06/2018 - 01/2016
2	ElectrolytesIBA 06/2018 - 01/2016
2	AlbuminsIBA 01/2017 - 01/2017
2	SRT1720IBA 01/2017 - 12/2016
2	1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA 01/2017 - 08/2016
2	Heme (Haem)IBA 01/2017 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 01/2017
2	Estrogens (Estrogen)FDA Link 11/2016 - 08/2016

Therapy/Procedure

14	Therapeutics 04/2022 - 07/2011
3	Liver Transplantation 08/2022 - 12/2020
3	Lung Transplantation 01/2021 - 04/2019
2	Phage Therapy 01/2022 - 12/2020
2	Radiotherapy 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
2	Stents 07/2021 - 10/2017
2	Ligation 11/2020 - 10/2018